Home › Companies › CELLDEX THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and CELLDEX THERAPEUTICS INC.’s Form 8-K, filed 2024-06-14 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore CELLDEX THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are CELLDEX THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Karen L. Shoos (Chair of the Board) | 54,662,615 | 791,355 | 113,213 | -- | 2,522,112 | Majority: yes |
| Elect Director: Anthony S. Marucci (Chief Executive Officer) | 54,704,706 | 749,690 | 112,787 | -- | 2,522,112 | Majority: yes |
| Elect Director: Keith L. Brownlie | 54,774,708 | 679,666 | 112,809 | -- | 2,522,112 | Majority: yes |
| Elect Director: Cheryl L. Cohen | 54,830,898 | 622,096 | 114,189 | -- | 2,522,112 | Majority: yes |
| Elect Director: Herbert J. Conrad | 53,985,260 | 1,469,124 | 112,799 | -- | 2,522,112 | Majority: yes |
| Elect Director: Rita I. Jain, M.D. | 54,826,340 | 627,680 | 113,163 | -- | 2,522,112 | Majority: yes |
| Elect Director: James J. Marino | 54,670,676 | 783,775 | 112,732 | -- | 2,522,112 | Majority: yes |
| Elect Director: Garry A. Neil, M.D. | 54,807,327 | 645,682 | 114,174 | -- | 2,522,112 | Majority: yes |
| Elect Director: Harry H. Penner, Jr. | 54,658,404 | 795,521 | 113,258 | -- | 2,522,112 | Majority: yes |
| Proposal 2: The stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. | 57,840,728 | 122,376 | 126,191 | -- | -- | Majority: yes |
| Proposal 3: The stockholders approved an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,200,000 shares to 7,500,000 shares. | 53,889,397 | 1,561,316 | 116,470 | -- | 2,522,112 | Majority: yes |
| Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement. | 54,182,916 | 945,004 | 439,263 | -- | 2,522,112 | Majority: yes |
Source: CELLDEX THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-14 — read the filing on EDGAR.
Each item below shows how the 201 asset managers that disclosed a CELLDEX THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”): 54,182,916 for, 945,004 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 82% for, 1% against (84% of the company cast a for/against vote).
The 201 asset managers below cast 99.0% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 18,612,434 | 0 | 0 | 0 | For |
| Vanguard | 8,180,153 | 0 | 0 | 0 | For |
| Wellington | 7,610,053 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,657,411 | 0 | 0 | 0 | For |
| State Street | 4,189,484 | 0 | 0 | 0 | For |
| BlackRock | 3,279,441 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 2,979,257 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 2,509,189 | 0 | Abstain |
| GEODE CAPITAL MANAGEMENT, LLC | 1,415,287 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 1,372,185 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,229,463 | 0 | 0 | 0 | For |
| Charles Schwab | 1,004,880 | 0 | 0 | 0 | For |
| COMMODORE CAPITAL LP | 866,468 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 810,954 | 0 | 0 | 0 | For |
| Woodline Partners LP | 728,244 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 650,000 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 648,737 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 582,726 | 0 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 526,357 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 497,270 | 0 | 0 | 0 | For |
| Nuveen | 371,953 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 371,219 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
Showing the 25 largest of 201 asset managers. See all 201 in the interactive database.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 3: The stockholders approved an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,200,000 shares to 7,500,000 shares.”): 53,889,397 for, 1,561,316 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 82% for, 2% against (84% of the company cast a for/against vote).
The 67 asset managers below cast 98% of the shares they voted on this item FOR (29,836,719 for, 489,081 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 2,509,189 | 0 | Abstain |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,208 | 251 | 0 | 0 | For |
| Eversept Partners, LP | 648,737 | 0 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 41,276 | 299,896 | 0 | 0 | Against |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 0 | 155,788 | 0 | 0 | Against |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Anthony S. Marucci (Chief Executive Officer)”): 54,704,706 for, 749,690 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 83% for, 1% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,676,409 for, 221 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,238 | 221 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Cheryl L. Cohen”): 54,830,898 for, 622,096 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 83% for, 1.0% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,676,468 for, 162 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,297 | 162 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Garry A. Neil, M.D.”): 54,807,327 for, 645,682 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 83% for, 1.0% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,669,735 for, 6,895 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,105 | 354 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Harry H. Penner, Jr.”): 54,658,404 for, 795,521 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 83% for, 1% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,668,407 for, 8,223 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,046 | 413 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Herbert J. Conrad”): 53,985,260 for, 1,469,124 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 82% for, 2% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,661,674 for, 14,956 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,501,854 | 605 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: James J. Marino”): 54,670,676 for, 783,775 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 83% for, 1% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,676,468 for, 162 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,297 | 162 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Karen L. Shoos (Chair of the Board)”): 54,662,615 for, 791,355 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 83% for, 1% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,676,409 for, 221 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,238 | 221 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Keith L. Brownlie”): 54,774,708 for, 679,666 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 83% for, 1% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,676,468 for, 162 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,297 | 162 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 2: The stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.”): 57,840,728 for, 122,376 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 88% for, 0.2% against (88% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,676,379 for, 251 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,161,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,208 | 251 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Rita I. Jain, M.D.”): 54,826,340 for, 627,680 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 65,910,548 outstanding shares: 83% for, 1.0% against (84% of the company cast a for/against vote).
The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (29,622,235 for, 6,895 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,368,618 | 0 | 0 | 0 | For |
| Vanguard | 8,068,532 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,113,701 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,485,625 | 0 | 0 | 0 | For |
| BlackRock | 1,550,187 | 0 | 0 | 0 | For |
| State Street | 1,502,105 | 354 | 0 | 0 | For |
| Hartford | 582,176 | 0 | 0 | 0 | For |
| Charles Schwab | 502,440 | 0 | 0 | 0 | For |
| TIAA | 369,232 | 0 | 0 | 0 | For |
| Prudential/PGIM | 341,172 | 0 | 0 | 0 | For |
| Equitable | 172,663 | 0 | 0 | 0 | For |
| American Century | 155,788 | 0 | 0 | 0 | For |
| John Hancock | 134,953 | 0 | 0 | 0 | For |
| Northwestern Mutual | 99,267 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 87,220 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 83,047 | 0 | 0 | 0 | For |
| First Trust | 78,073 | 0 | 0 | 0 | For |
| Brighthouse | 71,470 | 0 | 0 | 0 | For |
| Invesco | 70,952 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 67,207 | 0 | 0 | 0 | For |
| Principal | 51,902 | 0 | 0 | 0 | For |
| Lincoln Financial | 50,600 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 49,440 | 0 | 0 | 0 | For |
| Goldman Sachs | 45,216 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 45,088 | 0 | 0 | 0 | For |
Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.
Ranked by the number of CELLDEX THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 65,910,548 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 28.24% |
| 2 | Vanguard | 12.41% |
| 3 | Wellington | 11.55% |
| 4 | T. Rowe Price | 8.58% |
| 5 | State Street | 6.36% |
| 6 | BlackRock | 4.98% |
| 7 | MUTUAL FUND SERIES TRUST | 4.80% |
| 8 | Polar Capital Holdings Plc | 4.52% |
| 9 | Kynam Capital Management, LP | 3.81% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.15% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Wellington Management | 11.60% | 13F |
| FMR LLC | 10.70% | DEF14A |
| BlackRock | 8.35% | 13F |
| FMR (Fidelity) | 7.53% | 13F |
| Vanguard Group | 6.00% | 13F |
| Eventide Asset Management, LLC. | 5.51% | DEF14A |
| RTW Investments, LP | 5.25% | DEF14A |
| T. Rowe Price | 4.68% | 13F |
| State Street | 4.52% | 13F |
| Geode Capital | 2.15% | 13F |
Percentages above are of 65,910,548 shares outstanding, as reported by CELLDEX THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CELLDEX THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At CELLDEX THERAPEUTICS INC.'s shareholder meeting held 2024-06-13, in the 2023-2024 proxy season, 201 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 2,950 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CELLDEX THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-14.
CELLDEX THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.